President Bio reaffirmed Africa's unwavering position, stressing that the continent seeks not less than two permanent seats with full prerogatives, including the veto, and five non-permanent seats.
A program getting middle and high schoolers outdoors in San Mateo County is looking to do far more than get kids’ hands dirty, it is working to develop deep connections between the youth and the natural world to better combat ... .
INmune Bio Advances CORDStrom™ Towards UK Marketing Authorization in RDEB... 10, 2026 (GLOBE NEWSWIRE) -- INmune Bio Inc ... While advancing the regulatory pathway in the UK, INmune Bio also stands to benefit from recent U.S ... About INmune Bio Inc.
NEW YORK, Feb. 12, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Instil Bio, Inc. ("Instil" or the "Company") (NASDAQ... On January 6, 2026, Instil issued a press release announcing that Axion Bio, Inc ... . ... 7980 ... 21% ... .
13, 2026 /CNW/ - CTK Bio has developed a breakthrough sustainable superabsorbent technology that delivers improved performance while addressing key environmental challenges in the personal hygiene market ... CTK Bio - Hydrogel (CNW Group/CTK Bio).
) Feb. 13, 2026 TSE Designation of Securities Under Supervision (Confirmation). TAKARABIOINC. Post. TSE has designated an issue as a Security Under Supervision (Confirmation) as follows. 1.Issue Name TAKARA BIO INC ... 3.Details of Reason TAKARA BIO INC.
) STADA and Bio-Thera receive European Marketing Authorization for Gotenfia, a Biosimilar to Simponi. European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA.
"Building on our prior approvals and launches in the US and EU, this European authorization further establishes Bio-Thera as a major global biosimilar developer and manufacturer." ... Bio-Thera ContactsBio-Thera Solutions, LtdBert E.